SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-067930
Filing Date
2022-03-07
Accepted
2022-03-07 16:06:42
Documents
6
Effectiveness Date
2022-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d295777ds8.htm S-8 42394
2 EX-5.1 d295777dex51.htm EX-5.1 11498
3 EX-23.1 d295777dex231.htm EX-23.1 1580
4 EX-FILING FEES d295777dexfilingfees.htm EX-FILING FEES 24684
5 GRAPHIC g295777sp6.jpg GRAPHIC 3787
6 GRAPHIC g295777sp7a.jpg GRAPHIC 2397
  Complete submission text file 0001193125-22-067930.txt   89976
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263340 | Film No.: 22718047
SIC: 2834 Pharmaceutical Preparations